PT  - JOURNAL ARTICLE
AU  - Sharma, Vikas Kumar
AU  - Nigam, Unnati
TI  - Modeling and Forecasting of Covid-19 growth curve in India
AID  - 10.1101/2020.05.20.20107540
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.20.20107540
4099  - http://medrxiv.org/content/early/2020/07/17/2020.05.20.20107540.short
4100  - http://medrxiv.org/content/early/2020/07/17/2020.05.20.20107540.full
AB  - In this article, we analyze the growth pattern of Covid-19 pandemic in India from March 4th to July 11th using regression analysis (exponential and polynomial), auto-regressive integrated moving averages (ARIMA) model as well as exponential smoothing and Holt-Winters smoothing models. We found that the growth of Covid-19 cases follows a power regime of (t2,t,..) after the exponential growth. We found the optimal change points from where the Covid-19 cases shift their course of growth from exponential to quadratic and then from quadratic to linear. After that, we saw a sudden spike in the course of the spread of Covid-19 and the growth moved from linear to quadratic and then to quartic, which is alarming. We have also found the best fitted regression models using the various criteria such as significant p-values, coefficients of determination and ANOVA etc. Further, we search the best fitting ARIMA model for the data using the AIC (Akaike Information Criterion) and provide the forecast of Covid-19 cases for future days. It was noticed that the ARIMA model fits better the Covid-19 cases for small regions. ARIMA (5, 2, 5) and ARIMA (5, 2, 3) are the best possible models for modeling Covid-19 cases for March 4th to July 10th and June 1th to July 10th, respectively.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding for this work. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is available at GitHub, provided by John Hopkins University. 15.https://github.com/CSSEGISandData/COVID-19/blob/master/csse_covid_19_data/csse_covid_19_time_series/time_series_covid19_confirmed_global.csv